Every PCR test, every next-generation sequencing run, every mRNA therapeutic in development shares one invisible chokepoint: before you can read, amplify, or manipulate DNA or RNA, you have to extract it cleanly. That single step — nucleic acid isolation and purification — has quietly become a USD 6.1 billion global market in 2025, projected to reach USD 12.8 billion by...